A Chimeric Virus-Mouse Model System for Evaluating the Function and Inhibition of Papain-Like Proteases of Emerging Coronaviruses
Public Deposited
Add to collection
You do not have access to any existing collections. You may create a new collection.
Citation
MLA
Deng, Xufang, et al. A Chimeric Virus-mouse Model System for Evaluating the Function and Inhibition of Papain-like Proteases of Emerging Coronaviruses. American Society for Microbiology , 2014. https://doi.org/10.17615/aftx-3z93APA
Deng, X., Agnihothram, S., M. Mielech, A., B. Nichols, D., W. Wilson, M., E. St. John, S., D. Larsen, S., D. Mesecar, A., J. Lenschow, D., S. Baric, R., & Baker, S. (2014). A Chimeric Virus-Mouse Model System for Evaluating the Function and Inhibition of Papain-Like Proteases of Emerging Coronaviruses. American Society for Microbiology . https://doi.org/10.17615/aftx-3z93Chicago
Deng, Xufang, Sudhakar Agnihothram, Anna M. Mielech, Daniel B. Nichols, Michael W. Wilson, Sarah E. St. John, Scott D. Larsen et al. 2014. A Chimeric Virus-Mouse Model System for Evaluating the Function and Inhibition of Papain-Like Proteases of Emerging Coronaviruses. American Society for Microbiology . https://doi.org/10.17615/aftx-3z93- Creator
-
Xufang Deng
- Other Affiliation: Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA
-
Sudhakar Agnihothram
- Other Affiliation: Departments of Epidemiology and Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA
-
Anna M. Mielech
- Other Affiliation: Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA
-
Daniel B. Nichols
- Other Affiliation: Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA
-
Michael W. Wilson
- Other Affiliation: Vahlteich Medicinal Chemistry Core, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA
-
Sarah E. St. John
- Other Affiliation: Departments of Biological Science and Chemistry, Purdue University, West Lafayette, Indiana, USA
-
Scott D. Larsen
- Other Affiliation: Vahlteich Medicinal Chemistry Core, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA
-
Andrew D. Mesecar
- Other Affiliation: Departments of Biological Science and Chemistry, Purdue University, West Lafayette, Indiana, USA
-
Deborah J. Lenschow
- Other Affiliation: Department of Internal Medicine and Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
-
Ralph S. Baric
- Other Affiliation: Departments of Epidemiology and Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA
-
Susan Baker
- ORCID: https://orcid.org/0000-0001-6485-8143
- Other Affiliation: Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA
- Abstract
- To combat emerging coronaviruses, developing safe and efficient platforms to evaluate viral protease activities and the efficacy of protease inhibitors is a high priority. Here, we exploit a biosafety level 2 (BSL-2) chimeric Sindbis virus system to evaluate protease activities and the efficacy of inhibitors directed against the papain-like protease (PLpro) of severe acute respiratory syndrome coronavirus (SARS-CoV), a biosafety level 3 (BSL-3) pathogen. We engineered Sindbis virus to coexpress PLpro and a substrate, murine interferon-stimulated gene 15 (ISG15), and found that PLpro mediates removal of ISG15 (deISGylation) from cellular proteins. Mutation of the catalytic cysteine residue of PLpro or addition of a PLpro inhibitor blocked deISGylation in virus-infected cells. Thus, deISGylation is a marker of PLpro activity. Infection of alpha/beta interferon receptor knockout (IFNAR−/−) mice with these chimeric viruses revealed that PLpro deISGylation activity removed ISG15-mediated protection during viral infection. Importantly, administration of a PLpro inhibitor protected these mice from lethal infection, demonstrating the efficacy of a coronavirus protease inhibitor in a mouse model. However, this PLpro inhibitor was not sufficient to protect the mice from lethal infection with SARS-CoV MA15, suggesting that further optimization of the delivery and stability of PLpro inhibitors is needed. We extended the chimeric-virus platform to evaluate the papain-like protease/deISGylating activity of Middle East respiratory syndrome coronavirus (MERS-CoV) to provide a small-animal model to evaluate PLpro inhibitors of this recently emerged pathogen. This platform has the potential to be universally adaptable to other viral and cellular enzymes that have deISGylating activities.
- Date of publication
- 2014
- Keyword
- DOI
- Related resource URL
- Resource type
- Article
- Rights statement
- In Copyright
- Journal title
- Journal of Virology
- Journal volume
- 88
- Journal issue
- 20
- Page start
- 11825
- Page end
- 11833
- Language
- English
- ISSN
- 1098-5514
- 1070-6321
- 0022-538X
- Publisher
- American Society for Microbiology
Relations
- Parents:
- In Collection:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
|
zjv11825.pdf | 2020-04-06 | Public | Download |